Indications
Seizures. Agitated or violent patients in a behavioral emergency. Agitation in SSRI or TCA overdose, and temperature control in MAOI overdose. Shivering that prevents effective cooling in heat illness.
Contraindications
Known hypersensitivity, severe respiratory depression, sleep apnea
Adult dose
Seizure, no IV or IO: 0.2 mg/kg IM (preferred) or IN, max 10 mg
Seizure, IV or IO in place: 0.1 mg/kg IV or IO, max 4 mg
Agitation: 5 mg IV (onset 3-5 min), 5 mg IM (onset 10-15 min) or 5 mg IN (onset 3-5 min)
Agitation in SSRI or TCA overdose: 0.1 mg/kg slow IV push in 2 mg increments, each over 1-2 min, max single dose 5 mg. Reduce by 50% at age 69 or older
Temperature control in MAOI overdose: 0.1 mg/kg slow IV push in 2 mg increments, each over 1-2 min, max single dose 5 mg. Reduce by 50% at age 69 or older
Shivering that prevents cooling in heat illness: 2.5 mg IV or IN, may repeat once in 5 min, or 5 mg IM, may repeat once in 10 min
Nerve agent or organophosphate seizures: 10 mg IM, may repeat once in 10 min as needed, max total 20 mg
Pediatric dose
Seizure, no IV or IO: 0.2 mg/kg IM (preferred) or IN, max 10 mg
Seizure, IV or IO in place: 0.1 mg/kg IV or IO, max 4 mg
Agitation: 0.05-0.1 mg/kg IV (max 5 mg), 0.1-0.15 mg/kg IM (max 5 mg) or 0.3 mg/kg IN (max 5 mg)
Agitation in SSRI or TCA overdose: 0.1 mg/kg slow IV push in 2 mg increments, each over 1-2 min, max single dose 4 mg, or 0.2 mg/kg IN, max single dose 10 mg
Temperature control in MAOI overdose: 0.1 mg/kg slow IV push in 2 mg increments, each over 1-2 min, max single dose 5 mg
Route
IV, IO, IM, IN
Special considerations
For a seizure, IM or IN is the preferred route. You don't need an IV to treat a seizure. More than two benzodiazepine doses carry a high risk of airway compromise. It can cause respiratory depression or apnea, so watch breathing closely and use capnography if you have it. Do not give IM or IV benzodiazepines with IM olanzapine. Deaths have been reported.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Seizures; Agitated or Violent Patient/Behavioral Emergency; Poisoning/Overdose Universal Care; Hyperthermia/Heat Exposure; Acetylcholinesterase Inhibitors (Carbamates, Nerve Agents, Organophosphates) Exposure. Levels from the National EMS Scope of Practice Model (2019).